Carbonic anhydrase IX and hypoxia-inducible factor 1 attenuate cardiac dysfunction after myocardial infarction

Mariela Beatriz Nolly1, Lorena Alejandra Vargas2, María Verónica Correa3

  • 1Laboratorio de Bioquímica e Inmunidad, IMBECU-CONICET-UNCuyo, Instituto de Bioquímica y Biotecnología, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, 5500, Mendoza, Argentina. mariela.nolly@gmail.com.

Insights

Hypoxia-inducible factor (HIF-1) activation in myocardial infarction (MI) boosts carbonic anhydrase IX (CAIX) and sodium bicarbonate transporter 1 (NBC1). This interaction protects heart tissue from acidic damage, improving cardiac function post-MI.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Cellular Physiology

Background:

  • Myocardial infarction (MI) significantly impacts global mortality, with infarct size and cardiac remodeling dictating prognosis and heart failure risk.
  • Hypoxia-inducible factor 1 (HIF-1) activation in hypoxic regions post-MI is known to reduce infarct size and improve cardiac function.
  • HIF-1 activation leads to the transcription of carbonic anhydrase IX (CAIX), an enzyme crucial for regulating intracellular pH in the heart.

Purpose of the Study:

  • To investigate the role of carbonic anhydrase IX (CAIX) in cardiac remodeling following myocardial infarction (MI).
  • To explore the relationship between CAIX, sodium bicarbonate transporter 1 (NBC1), and HIF-1 in the context of post-MI cardiac remodeling.
  • To elucidate the potential protective mechanisms involving CAIX and NBC1 in hypoxic heart tissue.

Main Methods:

  • Utilized an in vivo rat coronary artery ligation model to simulate myocardial infarction.
  • Employed isolated cardiomyocytes subjected to hypoxic conditions for in vitro analysis.
  • Applied immunohistochemistry, immunoblotting, confocal microscopy, and immunoprecipitation to assess protein expression and interactions.

Main Results:

  • Increased HIF-1 levels were observed in infarcted cardiac tissue and hypoxic cardiomyocytes within 2 hours.
  • Carbonic anhydrase IX (CAIX) expression and plasma membrane localization increased post-MI, particularly at 24 hours.
  • Sodium bicarbonate transporter 1 (NBC1) expression rose in cardiac tissue after 2 hours of infarction, and CAIX-NBC1 interaction was enhanced in MI tissue.

Conclusions:

  • CAIX interacts with NBC1 in the context of myocardial infarction, suggesting a protective mechanism against acidic damage in hypoxic cardiac tissue.
  • This CAIX-NBC1 interaction represents a potential therapeutic target for mitigating adverse cardiac remodeling and improving outcomes after MI.
  • The findings highlight the critical role of pH regulation via CAIX and NBC1 in preserving cardiac function during and after ischemic events.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.1K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
612
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
78
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
122
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
948